These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28001499)

  • 1. Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients.
    Cabello Zurita C; Grau Pérez M; Hernández Fernández CP; González Quesada A; Valerón Almazán P; Vilar Alejo J; Carretero Hernández G
    J Dermatolog Treat; 2017 Aug; 28(5):401-405. PubMed ID: 28001499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of factors influencing target PASI responses and side effects of methotrexate monotherapy in plaque psoriasis: a multicenter study of 1521 patients.
    Erduran F; Emre S; Hayran Y; Adışen E; Polat AK; Üstüner P; Öztürkcan S; Öztürk P; Ermertcan AT; Selçuk LB; Aksu EK; Akbaş A; Kalkan G; Demirseren D; Kartal SP; Topkarcı Z; Kılıç A; Yaldız M; Aytekin S; Hızlı P; Gharehdaghi S; Borlu M; Işık L; Botsalı BR; Solak EÖ; Albayrak H; Gönülal M; Balcı DD; Polat M; Daye M; Ataseven A; Yıldız S; Özer İ; Zorlu Ö; Doğan S; Erdemir VA; Dikicier BS
    Arch Dermatol Res; 2024 May; 316(6):278. PubMed ID: 38796658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
    Tournier A; Khemis A; Maccari F; Reguiai Z; Bégon E; Fougerousse AC; Amy de la Breteque M; Beneton N; Parier J; Boyé T; Avenel-Audran M; Girard C; Pallure V; Perrot JL; Bastien M; Mahé E; Beauchet A;
    Ann Dermatol Venereol; 2019 Feb; 146(2):106-114. PubMed ID: 30704943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia.
    Ng LC; Lee YY; Lee CK; Wong SM
    Int J Dermatol; 2013 Jan; 52(1):102-5. PubMed ID: 23278617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S; Krishna V; Kanwar AJ
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
    Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting.
    Rademaker M; Gupta M; Andrews M; Armour K; Baker C; Foley P; Gebauer K; George J; Rubel D; Sullivan J
    Australas J Dermatol; 2017 Aug; 58(3):166-170. PubMed ID: 27402434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry.
    van Geel MJ; Oostveen AM; Hoppenreijs EP; Hendriks JC; van de Kerkhof PC; de Jong EM; Seyger MM
    J Dermatolog Treat; 2015 Oct; 26(5):406-12. PubMed ID: 25485870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse azathioprine and low-dose methotrexate vs. standard-dose methotrexate in treatment of patients with moderate-to-severe psoriasis: a randomized controlled trial.
    El-Komy MHM; Sayed KS; Gawish G; Elaguizy MM; Azzazi Y
    Clin Exp Dermatol; 2024 Aug; 49(9):1029-1035. PubMed ID: 38469732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.
    Montaudié H; Sbidian E; Paul C; Maza A; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():12-8. PubMed ID: 21388454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
    Kaur I; Dogra S; De D; Kanwar AJ
    Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
    Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
    J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.
    Otero ME; van den Reek JM; Seyger MM; van de Kerkhof PC; Kievit W; de Jong EM
    Br J Dermatol; 2017 Aug; 177(2):497-504. PubMed ID: 28078672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of methotrexate in patients with psoriasis.
    Kuhn A; Ruland V; Patsinakidis N; Luger TA
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S138-44. PubMed ID: 21044448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.